Results 91 to 100 of about 2,193 (158)

Curated Cases from the TB Expert Network: Unplugged!: Navigating Uncertainty in Treatment of a Child with Multidrug-Resistant Tuberculosis. [PDF]

J Clin Tuberc Other Mycobact Dis
Gaensbauer J, Harrison E, Wendorf K, Armitige L, Corriveau E, Haley CA, Weld ED, Chen L, Ramesh V, Goswami N.   +9 more
europepmc   +1 more source

Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis. [PDF]

Antimicrob Agents Chemother
Abdelwahab MT, Svensson EM, Diacon AH, Conradie A, Olugbosi M, Dawson R, Maartens G, Denti P.   +7 more
europepmc   +1 more source

Cerebral and bone multidrug resistant tuberculosis treated with the BPaLM regimen: case report. [PDF]

Front Pharmacol
Calamelli M, Davoli C, Gerami R, Gulletta M, Lovatti S, Pavesi A, Rossi B, Matteelli A.   +7 more
europepmc   +1 more source

Therapeutic drug monitoring-guided treatment of XDR TB with an RpoB I491F mutation-a case report. [PDF]

JAC Antimicrob Resist
Klingmüller A, Zuber S, Hoffmann AM, Köhler N, Suárez I, Preßel T, Niemann S, Dreyer V, Decosterd LA, Choong E, Schütz B, Friesen I, Rybniker J.   +12 more
europepmc   +1 more source

Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study. [PDF]

IJTLD Open
Lowton K, Stringer B, Cusinato M, Fielding K, Liverko I, Moodliar R, Nikolaevna TZ, Solodovnikova V, Kazounis E, Nyang'wa BT.   +9 more
europepmc   +1 more source

High-throughput characterization of Mycobacterium tuberculosis gene function across diverse conditions. [PDF]

PLoS Biol
Dinshaw KM, Lien KA, Knight M, Ouonkap SVY, Liu H, Savage DF, Carlson HK, Deutschbauer AM, Stanley SA.   +8 more
europepmc   +1 more source

An assay toolkit for anti-tuberculosis drugs in the hollow fiber system. [PDF]

iScience
Sanz-García F, Ndjogou D, Aguilar-Ayala DA, Eveque-Mourroux MR, Benítez A, Aznar S, Isach-Traver N, Mendoza-Losana A, Willand N, Lucía A, Ramón-García S, ERA4TB consortium.   +11 more
europepmc   +1 more source

Treatment of pre-extensively drug-resistant tuberculosis in a critically ill patient using bedaquiline, pretomanid, and linezolid therapy in Canada: A brief report. [PDF]

J Assoc Med Microbiol Infect Dis Can
Khuman HS, Laird PR, Samis AJW, Ma A.
europepmc   +1 more source

Effectiveness and safety of bedaquiline, pretomanid, linezolid and moxifloxacin in drug-resistant tuberculosis patients in selected public hospitals in Ethiopia: a multicenter retrospective cohort study. [PDF]

BMC Infect Dis
Solomon B, Seid A, Nadew T, Werku A, Mesfin T, Nigussie A, Sebro E, Gemechu R, Mekonnen E, Abate B, Eshetu A, Tigabie W, Solomon M, Mulu HT.   +13 more
europepmc   +1 more source

Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009). [PDF]

Trials
Olugbosi M, Beumont M, Lombard L, Nedelman J, Timm J, Black T, Bruning-Barry R, Hickman D, Lombardi A, Betteridge M, Egizi E, Marcopulos L, Henderson J, Seidel S, Foraida S, Benhayoun M, Sun E.   +16 more
europepmc   +1 more source